Summit Street Capital Management LLC Purchases New Holdings in Molina Healthcare, Inc $MOH

Key Points

• Summit Street Capital Management purchased 182,031 Molina Healthcare shares worth approximately $41.6 million, making MOH its second-largest holding and representing about 5.8% of its portfolio.
• Molina reported quarterly EPS of $1.51, beating the $1.39 analyst consensus, while revenue of $10.87 billion slightly exceeded estimates. However, revenue declined 4.8% year over year and net margin was nearly breakeven.
• Analysts maintain a broadly neutral view: Molina has a consensus “Hold” rating and an average price target of $202.44, with institutional investors owning approximately 98.5% of the stock.

Summit Street Capital Management LLC purchased a new stake in Molina Healthcare, Inc (NYSE:MOH - Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 182,031 shares of the company's stock, valued at approximately $41,630,000. Molina Healthcare makes up approximately 5.8% of Summit Street Capital Management LLC's investment portfolio, making the stock its 2nd biggest holding. Summit Street Capital Management LLC owned approximately 0.35% of Molina Healthcare at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the stock. ARGA Investment Management LP grew its stake in shares of Molina Healthcare by 1.4% in the first quarter. ARGA Investment Management LP now owns 4,166 shares of the company's stock valued at $555,000 after buying an additional 59 shares in the last quarter. Elevation Wealth Partners LLC raised its position in Molina Healthcare by 118.2% during the second quarter. Elevation Wealth Partners LLC now owns 144 shares of the company's stock worth $33,000 after acquiring an additional 78 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its position in Molina Healthcare by 64.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 232 shares of the company's stock worth $40,000 after acquiring an additional 91 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Molina Healthcare by 0.7% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,668 shares of the company's stock valued at $2,616,000 after acquiring an additional 92 shares during the last quarter. Finally, Public Employees Retirement System of Ohio lifted its stake in Molina Healthcare by 0.6% in the third quarter. Public Employees Retirement System of Ohio now owns 16,753 shares of the company's stock valued at $3,206,000 after acquiring an additional 104 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company's stock.

Molina Healthcare Stock Up 1.6%

MOH stock opened at $202.74 on Thursday. Molina Healthcare, Inc has a fifty-two week low of $121.06 and a fifty-two week high of $244.89. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.68 and a quick ratio of 1.68. The stock has a market capitalization of $10.58 billion, a price-to-earnings ratio of -1,126.27, a PEG ratio of 28.61 and a beta of 0.75. The business's fifty day moving average price is $211.34 and its two-hundred day moving average price is $179.02.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its earnings results on Wednesday, July 22nd. The company reported $1.51 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.12. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. The company had revenue of $10.87 billion during the quarter, compared to analysts' expectations of $10.83 billion. During the same quarter in the previous year, the business posted $5.48 earnings per share. Molina Healthcare's quarterly revenue was down 4.8% on a year-over-year basis. On average, equities analysts anticipate that Molina Healthcare, Inc will post 5.29 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts have recently weighed in on MOH shares. TD Cowen boosted their price objective on shares of Molina Healthcare from $163.00 to $230.00 and gave the stock a "hold" rating in a research note on Tuesday, July 14th. Wells Fargo & Company lowered their price target on Molina Healthcare from $235.00 to $220.00 and set an "equal weight" rating on the stock in a research report on Tuesday, July 28th. Truist Financial cut their price objective on Molina Healthcare from $250.00 to $225.00 and set a "hold" rating for the company in a research report on Friday, July 24th. Jefferies Financial Group set a $230.00 price target on Molina Healthcare in a research note on Tuesday, July 14th. Finally, Sanford C. Bernstein set a $286.00 price objective on shares of Molina Healthcare in a research report on Monday, July 13th. Three equities research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Molina Healthcare has a consensus rating of "Hold" and a consensus price target of $202.44.

Molina Healthcare News Roundup

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Molina’s latest quarterly results exceeded expectations, with earnings of $1.51 per share versus the $1.39 consensus forecast and revenue of $10.87 billion, slightly above estimates. A recent analysis described the shares as a potential bargain following the strong results. Molina Healthcare Stock Looks Like a Bargain After Strong Q1 Results
• Positive Sentiment: Zacks Research raised its estimates for second-quarter 2027 EPS to $2.39 from $2.22 and for fiscal 2028 EPS to $12.22 from $11.94. The analyst maintained a “Strong Buy” rating in those estimates, signaling confidence in Molina’s longer-term earnings potential. Molina Healthcare analyst estimates
• Neutral Sentiment: Zacks’ broader industry outlook highlighted Molina alongside UnitedHealth, Cigna, Humana and Centene, indicating that managed-care industry trends remain an important factor for MOH investors. Zacks Industry Outlook on Molina and managed-care companies
• Negative Sentiment: Several Zacks revisions lowered near- to medium-term projections: Q3 2026 EPS fell to $0.71 from $0.72, fiscal 2026 EPS to $5.27 from $5.28, Q3 2027 EPS to $2.24 from $2.42, Q4 2027 EPS to $2.12 from $2.87, and fiscal 2027 EPS to $9.28 from $10.05.
• Negative Sentiment: The latest quarter also showed pressure beneath the headline beat: revenue declined 4.8% year over year, compared with $5.48 EPS in the prior-year period, while Molina reported a nearly breakeven net margin. Most Zacks coverage remains at a “Hold” rating.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source